Phase I trial of ALLN 177 in healthy volunteers on a high oxalate diet.
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2016
Price : $35 *
At a glance
- Drugs Reloxaliase (Primary)
- Indications Hyperoxaluria
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Allena Pharmaceuticals
- 17 Nov 2014 According to an Allena Pharmaceuticals media release, data of this study were presented at the American Society of Nephrology (ASN) Kidney Week 2014.
- 06 May 2014 New trial record
- 29 Apr 2014 Results reported in an Allena Pharmaceuticals media release.